Vetter Pharma Fertigung GmbH & Co. KG (Ravensburg Mooswiesen)February 9, 2018

FDA 483 - Vetter Pharma Fertigung GmbH & Co. KG (Ravensburg Mooswiesen) - February 09, 2018

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

An FDA inspection of Vetter Pharma Fertigung Gmbg & Co. KG in Ravensburg, Germany, identified a significant issue regarding the firm's risk assessment processes. Specifically, the assessment supporting media fills lacked comprehensive details and evaluations. This indicates a moderate severity finding related to quality control and manufacturing practices.

Company: Vetter Pharma Fertigung GmbH & Co. KG (Ravensburg Mooswiesen)
Inspection Date: February 9, 2018
Product Type: Drugs
Office: Office of Inspections and Investigations
People: Thuy T. Nguyen ( Investigator, Consumer Safety Officer)
Michael R. Klapal (Investigator)

Open in Dashboard

ID · d2c2a04a-70fd-47d0-9898-d4c6ae6f5b44